Subhecchha Baidya

ORCID: 0009-0005-4852-246X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tuberculosis Research and Epidemiology
  • Antibiotic Resistance in Bacteria
  • Cancer therapeutics and mechanisms

Indian Institute of Technology Roorkee
2021

The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis calls for an immediate search novel treatment strategies. Recently, BlaC, the principal beta-lactamase Mycobacterium tuberculosis, was recognized as a potential therapeutic target. BlaC belongs to Ambler class A, which is generally susceptible inhibitors currently used in clinics: tazobactam, sulbactam, clavulanate. Alterations at Ser130 conserved SDN loop confer resistance mechanism-based (MBIs)...

10.3389/fmicb.2021.710291 article EN cc-by Frontiers in Microbiology 2021-10-08
Coming Soon ...